MAQTOX and Telomir Pharmaceuticals Partner to Tackle Age-Related Inflammation with Telomir-1
In a significant development within the field of aging research, MAQTOX has partnered with Telomir Pharmaceuticals to tackle one of the most common and debilitating conditions associated with aging chronic inflammation. This collaboration is around their promising lead.
MAQTOX Announces Breakthrough in Drug Discovery with New Preclinical Data for Anti-Aging Compound
MAQTOX, a leader in drug discovery and development, recently presented a groundbreaking update on one of its most promising anti-aging compounds at the 2024 National University Health System (NUHS) Singapore.
